Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Luminescent Nanocrystal Tags Enable Multiple Pathogen Detection

By LabMedica International staff writers
Posted on 21 May 2014
The use of tunable luminescent nanocrystals as tags to advance medical imaging has been successfully applied to high-speed scanning technology and can detect multiple viruses within minutes.

A way to control the length of time light from a luminescent nanocrystal lingers, has been developed which introduces the dimension of time in addition to color and brightness in optical detection technology. More...
Detection based on the lifetime of the light from a nanocrystal as well as its specific color exponentially increases the possible combinations and unique tags that could be created for biomedical screens.

Scientists at Macquarie University (Sydney, Australia) and Purdue University (West Lafayette, IN, USA) attached unique tags to DNA strands of human immunodeficiency virus (HIV), Ebolavirus, Hepatitis B virus, and Human Papillomavirus 16. The tags were accurately read and distinguished at high speeds in suspension arrays.

To further extend optical time-domain multiplexing to the down conversion luminescence, they used luminescence microspheres where lifetimes are tuned through luminescence resonance energy transfer. They decoded luminescence lifetimes in the microsecond region for lanthanide-encoded suspension arrays. This was accomplished by time-resolved orthogonal scanning automated microscopy (TR-OSAM) modified on an epi-fluorescence Olympus IX71 inverted microscope (Olympus America; Center Valley, PA, USA).

The authors concluded that they were able to demonstrate that luminescence lifetimes of microscopic targets in the microsecond region can be measured rapidly and precisely in a simple fashion. Their TR-OSAM system was rapid, sensitive and accurate in resolving the luminescence lifetimes from individual microspheres prepared by the luminescence resonance energy transfer scheme, which can be used to simultaneously probe multiple analytes, such as DNA strands.

Yiqing Lu, PhD, who led the study said, “We now are able to build a huge library of lifetime color-coded microspheres to perform multiple medical tasks or diagnoses at the same time. The time saved by omitting the need to grow or amplify a culture sample for testing and eliminating the need to run multiple tests will save future patients precious time so treatment can begin, which can be life-saving when managing aggressive diseases.” The study was published on May 6, 2014, in the journal Nature Communications.

Related Links:

Macquarie University
Purdue University
Olympus America



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.